Pathalys is a clinical biopharmaceutical company dedicated to developing innovative therapeutics for late-stage chronic kidney disease. Its initial focus is on addressing the unmet need of secondary hyperparathyroidism, aiming to enhance treatment options and improve patient outcomes in this critical area of healthcare.
Pathalys Pharma data powered by:
Share
Pathalys Pharma data powered by:
Pathalys PharmaOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
Pathalys PharmaIndustry Rankings in
Healthtech
City Rank
Share
Loading...
In Raleigh
Top null%out of startups
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
Pathalys PharmaSubindustry Rankings in
BiotechnologyCity Rank
Share
Loading...
In Raleigh
Top null%out of startups
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
rankings by:
Pathalys PharmaSB Rank Evolution
Not enough data points to display the chart.
Pathalys PharmastartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro